Isoptin

Verapamil, the active ingredient in Isoptin, is a calcium channel blocker presented as an oral tablet for oral use. It is employed to manage hypertension, angina pectoris, and certain cardiac arrhythmias, particularly in adult patients requiring rate control or vasodilation.

GNH USA supplies Isoptin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable global distribution.

Isoptin, a calcium channel blocker, is indicated for several cardiovascular conditions.

- Hypertension: lowers blood pressure by causing arterial vasodilation and reducing peripheral resistance. - Angina pectoris: relieves chest pain by decreasing myocardial oxygen demand through reduced contractility and heart rate. - Cardiac arrhythmias (e.g., supraventricular tachycardia): controls abnormal heart rhythms by slowing AV nodal conduction and prolonging refractory period.

Verapamil may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Dizziness: light‑headedness due to lowered blood pressure. - Headache: vascular dilation. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure drop. - Bradycardia: abnormally slow heart rate. - Heart block: impaired AV nodal conduction.

When prescribing Isoptin, clinicians should consider several safety measures.

- Blood pressure monitoring: check regularly during initiation and dose changes. - Cardiac function assessment: evaluate for heart failure before use. - Drug interactions: review concomitant medications, especially beta‑blockers and digoxin. - Renal/hepatic impairment: adjust use cautiously in severe dysfunction. - Pregnancy and lactation: use only if benefits outweigh risks. - Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture.

Verapamil interacts with several medicines; awareness helps prevent adverse events.

Major Interactions (Avoid): - Beta‑blockers: additive negative chronotropic effect may cause severe bradycardia. - Digoxin: increased risk of AV block. - CYP3A4 inhibitors (e.g., ketoconazole): may raise verapamil plasma levels.

Moderate Interactions (Monitor Closely): - Diltiazem: combined calcium channel blockade can enhance hypotension. - Rifampin: may reduce verapamil concentrations. - NSAIDs: may attenuate antihypertensive effect.